2015-2025 Global Oncology Drugs Market Research by Type, End-Use and Region (COVID-19)

Publisher Name :
Date: 04-Jul-2020
No. of pages: 110

Summary

The global Oncology Drugs market is expected to reach xxx Million USD by 2025, with a CAGR of xx% from 2020 to 2025.

Further key aspects of the report indicate that:

Chapter 1: Market Definition and Segment by Type, End-Use & Major Regions Market Size

Chapter 2: Global Production & Consumption Market by Type and End-Use

Chapter 3: Europe Production & Consumption Market by Type and End-Use

Chapter 4: America Production & Consumption Market by Type and End-Use

Chapter 5: Asia Production & Consumption Market by Type and End-Use

Chapter 6: Oceania Production & Consumption Market by Type and End-Use

Chapter 7: Africa Production & Consumption Market by Type and End-Use

Chapter 8: Global Market Forecast by Type, End-Use and Region

Chapter 9: Company information, Sales, Cost, Margin, news etc.

Chapter 10: Market Competition by Companies and Market Concentration Ratio

Chapter 11: Market Impact by Coronavirus.

Chapter 12: Industry Summary

Market Segment as follows:

Key Companies

- Novartis A.G

- Laboratrio Cristlia

- Medley Genomics

- F. Hoffmann-La Roche Ltd

- Icon Plc.

- Sanofi S.A.

- Laboratoires Pierre Fabre

- Eurofarma Laboratrios S.A.

- Ach Laboratrios Farmacuticos S.A.

- Laboratorios IMA

Key Types

- Oral Therapy

- Injectable Therapy

Key End-Use

- Targeted Therapy

Chemotherapy

- Hormonal Therapy

- Biologic Therapy

This report can be dispatched within 24-48 Hours.

2015-2025 Global Oncology Drugs Market Research by Type, End-Use and Region (COVID-19)

Table of Contents

CHAPTER 1 MARKET OVERVIEW
1.1 Market Definition and Segment
1.1.1 Product Definition
1.1.2 Product Type
1.1.3 End-Use
1.1.4 Marketing Channel
1.2 Major Regions
1.2.1 Europe Market Size and Growth
Figure Europe Oncology Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Europe Oncology Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.2 America Market Size and Growth
Figure America Oncology Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure America Oncology Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.3 Asia Market Size and Growth
Figure Asia Oncology Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure AsiaOncology Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.4 Oceania Market Size and Growth
Figure Oceania Oncology Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Oceania Oncology Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.5 Africa Market Size and Growth
Figure Africa Oncology Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Africa Oncology Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
CHAPTER 2 GLOBAL MARKET SEGMENTATION
2.1 Global Production Overview
Table Global Oncology Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
2.2 Global Consumption Overview
Table Global Oncology Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
2.3 Global Production by Type
Table Global Oncology Drugs Revenue by Type, 2015-2020 (Million USD)
Figure Global Oncology Drugs Revenue Share by Type in 2020 (Million USD)
Table Global Oncology Drugs Production Volume by Type, 2015-2020 (Volume)
Figure Global Oncology Drugs Production Volume Share by Type in 2020 (Volume)
2.4 Global Consumption by End-Use
Table Global Oncology Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Global Oncology Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Table Global Oncology Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Global Oncology Drugs Consumption Volume Share by End-Use in 2020 (Volume)
2.5 Global Consumption by Region
Table Global Oncology Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Global Oncology Drugs Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 3 Europe MARKET SEGMENTATION
3.1 Europe Production Overview
Table Europe Oncology Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
3.2 Europe Consumption Overview
Table Europe Oncology Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
3.3 Europe Production by Type
Table Europe Oncology Drugs Revenue by Type, 2015-2020 (Million USD)
Figure Europe Oncology Drugs Revenue Share by Type in 2020 (Million USD)
Table Europe Oncology Drugs Production Volume by Type, 2015-2020 (Volume)
Figure Europe Oncology Drugs Production Volume Share by Type in 2020 (Volume)
3.4 Europe Consumption by End-Use
Table Europe Oncology Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Europe Oncology Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Table Europe Oncology Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Europe Oncology Drugs Consumption Volume Share by End-Use in 2020 (Volume)
3.5 Europe Consumption by Region
Table Europe Oncology Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Europe Oncology Drugs Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 4 AMERICA MARKET SEGMENTATION
4.1 America Production Overview
Table America Oncology Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
4.2 America Consumption Overview
Table America Oncology Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
4.3 America Production by Type
Table America Oncology Drugs Revenue by Type, 2015-2020 (Million USD)
Figure America Oncology Drugs Revenue Share by Type in 2020 (Million USD)
Table America Oncology Drugs Production Volume by Type, 2015-2020 (Volume)
Figure America Oncology Drugs Production Volume Share by Type in 2020 (Volume)
4.4 America Consumption by End-Use
Table America Oncology Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Figure America Oncology Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Table America Oncology Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Figure America Oncology Drugs Consumption Volume Share by End-Use in 2020 (Volume)
4.5 America Consumption by Region
Table America Oncology Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table America Oncology Drugs Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 5 ASIA MARKET SEGMENTATION
5.1 Asia Production Overview
Table Asia Oncology Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
5.2 Asia Consumption Overview
Table Asia Oncology Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
5.3 Asia Production by Type
Table Asia Oncology Drugs Revenue by Type, 2015-2020 (Million USD)
Figure Asia Oncology Drugs Revenue Share by Type in 2020 (Million USD)
Table Asia Oncology Drugs Production Volume by Type, 2015-2020 (Volume)
Figure Asia Oncology Drugs Production Volume Share by Type in 2020 (Volume)
5.4 Asia Consumption by End-Use
Table Asia Oncology Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Asia Oncology Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Table Asia Oncology Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Asia Oncology Drugs Consumption Volume Share by End-Use in 2020 (Volume)
5.5 Asia Consumption by Region
Table Asia Oncology Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Asia Oncology Drugs Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 6 OCEANIA MARKET SEGMENTATION
6.1 Oceania Production Overview
Table Oceania Oncology Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
6.2 Oceania Consumption Overview
Table Oceania Oncology Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
6.3 Oceania Production by Type
Table Oceania Oncology Drugs Revenue by Type, 2015-2020 (Million USD)
Figure Oceania Oncology Drugs Revenue Share by Type in 2020 (Million USD)
Table Oceania Oncology Drugs Production Volume by Type, 2015-2020 (Volume)
Figure Oceania Oncology Drugs Production Volume Share by Type in 2020 (Volume)
6.4 Oceania Consumption by End-Use
Table Oceania Oncology Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Oceania Oncology Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Table Oceania Oncology Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Oceania Oncology Drugs Consumption Volume Share by End-Use in 2020 (Volume)
6.5 Oceania Consumption by Region
Table Oceania Oncology Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Oceania Oncology Drugs Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 7 AFRICA MARKET SEGMENTATION
7.1 Africa Production Overview
Table Africa Oncology Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
7.2 Africa Consumption Overview
Table Africa Oncology Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
7.3 Africa Production by Type
Table Africa Oncology Drugs Revenue by Type, 2015-2020 (Million USD)
Figure Africa Oncology Drugs Revenue Share by Type in 2020 (Million USD)
Table Africa Oncology Drugs Production Volume by Type, 2015-2020 (Volume)
Figure Africa Oncology Drugs Production Volume Share by Type in 2020 (Volume)
7.4 Africa Consumption by End-Use
Table Africa Oncology Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Africa Oncology Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Table Africa Oncology Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Africa Oncology Drugs Consumption Volume Share by End-Use in 2020 (Volume)
7.5 Africa Consumption by Region
Table Africa Oncology Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Africa Oncology Drugs Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 8 GLOBAL MARKET FORECAST
8.1 Global Oncology Drugs Production Forecast
Figure Global Oncology Drugs Revenue and Growth Rate Forecast 2020E-2025F (Million USD)
Figure Global Oncology Drugs Production Volume and Growth Rate Forecast 2020E-2025F (Volume)
8.2 Global Oncology Drugs Forecast by Type
Table Global Oncology Drugs Revenue by Type, 2020E-2025F (Million USD)
Figure Global Oncology Drugs Revenue Share by Type in 2025 (Million USD)
Table Global Oncology Drugs Production Volume by Type, 2020E-2025F (Volume)
Figure Global Oncology Drugs Production Volume Share by Type in 2025 (Volume)
8.3 Global Oncology Drugs Forecast by End-Use (2020E-2025F)
Table Global Oncology Drugs Consumption Value by End-Use, 2020E-2025F (Million USD)
Figure Global Oncology Drugs Consumption Value Share by End-Use in 2025 (Million USD)
Table Global Oncology Drugs Consumption Volume by End-Use, 2020E-2025F (Volume)
8.4 Global Oncology Drugs Forecast by Region (2020E-2025F)
Table Global Oncology Drugs Consumption Value by Region, 2020E-2025F (Million USD)
Figure Global Oncology Drugs Consumption Value Share by Region in 2025 (Million USD)
Table Global Oncology Drugs Consumption Volume by Region, 2020E-2025F (Volume)
Figure Global Oncology Drugs Consumption Volume Share by Region in 2025 (Volume)
CHAPTER 9 GLOBAL MAJOR COMPANIES LIST
9.1 Novartis A.G
9.1.1 Novartis A.G Profile
Table Novartis A.G Overview List
9.1.2 Novartis A.G Products & Services
9.1.3 Novartis A.G Company Dynamics & News
9.1.4 Novartis A.G Business Operation Conditions
Table Business Operation of Novartis A.G (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.2 Laboratrio Cristlia
9.2.1 Laboratrio Cristlia Profile
Table Laboratrio Cristlia Overview List
9.2.2 Laboratrio Cristlia Products & Services
9.2.3 Laboratrio Cristlia Company Dynamics & News
9.2.4 Laboratrio Cristlia Business Operation Conditions
Table Business Operation of Laboratrio Cristlia (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.3 Medley Genomics
9.3.1 Medley Genomics Profile
Table Medley Genomics Overview List
9.3.2 Medley Genomics Products & Services
9.3.3 Medley Genomics Company Dynamics & News
9.3.4 Medley Genomics Business Operation Conditions
Table Business Operation of Medley Genomics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.4 F. Hoffmann-La Roche Ltd
9.4.1 F. Hoffmann-La Roche Ltd Profile
Table F. Hoffmann-La Roche Ltd Overview List
9.4.2 F. Hoffmann-La Roche Ltd Products & Services
9.4.3 F. Hoffmann-La Roche Ltd Company Dynamics & News
9.4.4 F. Hoffmann-La Roche Ltd Business Operation Conditions
Table Business Operation of F. Hoffmann-La Roche Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.5 Icon Plc.
9.5.1 Icon Plc. Profile
Table Icon Plc. Overview List
9.5.2 Icon Plc. Products & Services
9.5.3 Icon Plc. Company Dynamics & News
9.5.4 Icon Plc. Business Operation Conditions
Table Business Operation of Icon Plc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.6 Sanofi S.A.
9.6.1 Sanofi S.A. Profile
Table Sanofi S.A. Overview List
9.6.2 Sanofi S.A. Products & Services
9.6.3 Sanofi S.A. Company Dynamics & News
9.6.4 Sanofi S.A. Business Operation Conditions
Table Business Operation of Sanofi S.A. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.7 Laboratoires Pierre Fabre
9.7.1 Laboratoires Pierre Fabre Profile
Table Laboratoires Pierre Fabre Overview List
9.7.2 Laboratoires Pierre Fabre Products & Services
9.7.3 Laboratoires Pierre Fabre Company Dynamics & News
9.7.4 Laboratoires Pierre Fabre Business Operation Conditions
Table Business Operation of Laboratoires Pierre Fabre (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.8 Eurofarma Laboratrios S.A.
9.8.1 Eurofarma Laboratrios S.A. Profile
Table Eurofarma Laboratrios S.A. Overview List
9.8.2 Eurofarma Laboratrios S.A. Products & Services
9.8.3 Eurofarma Laboratrios S.A. Company Dynamics & News
9.8.4 Eurofarma Laboratrios S.A. Business Operation Conditions
Table Business Operation of Eurofarma Laboratrios S.A. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.9 Ach Laboratrios Farmacuticos S.A.
9.9.1 Ach Laboratrios Farmacuticos S.A. Profile
Table Ach Laboratrios Farmacuticos S.A. Overview List
9.9.2 Ach Laboratrios Farmacuticos S.A. Products & Services
9.9.3 Ach Laboratrios Farmacuticos S.A. Company Dynamics & News
9.9.4 Ach Laboratrios Farmacuticos S.A. Business Operation Conditions
Table Business Operation of Ach Laboratrios Farmacuticos S.A. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.10 Laboratorios IMA
9.10.1 Laboratorios IMA Profile
Table Laboratorios IMA Overview List
9.10.2 Laboratorios IMA Products & Services
9.10.3 Laboratorios IMA Company Dynamics & News
9.10.4 Laboratorios IMA Business Operation Conditions
Table Business Operation of Laboratorios IMA (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
PART 10 MARKET COMPETITION
10.1 Key Company Market Share
Table Global Oncology Drugs Sales Revenue 2015-2020E, by Companies, in USD Million
Table Global Oncology Drugs Sales Revenue Share, 2015-2020E, by Companies, in USD
Table Global Oncology Drugs Sales Volume by Companies, 2015-2020E (Volume)
Table Global Oncology Drugs Sales Volume Share by Companies, 2015-2020E (Volume)
10.2 Regional Market Concentration
Figure Europe Oncology Drugs Market Concentration Ratio in 2020E
Figure America Oncology Drugs Market Concentration Ratio in 2020E
Figure Asia Oncology Drugs Market Concentration Ratio in 2020E
Figure Oceania Oncology Drugs Market Concentration Ratio in 2020E
Figure Africa Oncology Drugs Market Concentration Ratio in 2020E
PART 11 CORONAVIRUS IMPACT ON Oncology Drugs INDUSTRY
11.1 Impact on Industry Upstream
11.2 Impact on Industry Downstream
11.3 Impact on Industry Channels
11.4 Impact on Industry Competition
11.5 Impact on Industry Obtain Employment
PART 12 Oncology Drugs INDUSTRY SUMMARY & CONCLUSION

List of Tables

Table Global Oncology Drugs Revenue by Type, 2015-2020 (Million USD)
Table Global Oncology Drugs Production Volume by Type, 2015-2020 (Volume)
Table Global Oncology Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Table Global Oncology Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Table Global Oncology Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Global Oncology Drugs Consumption Volume by Region, 2015-2020 (Volume)
Table Europe Oncology Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Europe Oncology Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Europe Oncology Drugs Revenue by Type, 2015-2020 (Million USD)
Table Europe Oncology Drugs Production Volume by Type, 2015-2020 (Volume)
Table Europe Oncology Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Table Europe Oncology Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Table Europe Oncology Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Europe Oncology Drugs Consumption Volume by Region, 2015-2020 (Volume)
Table America Oncology Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table America Oncology Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table America Oncology Drugs Revenue by Type, 2015-2020 (Million USD)
Table America Oncology Drugs Production Volume by Type, 2015-2020 (Volume)
Table America Oncology Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Table America Oncology Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Table America Oncology Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table America Oncology Drugs Consumption Volume by Region, 2015-2020 (Volume)
Table Asia Oncology Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Asia Oncology Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Asia Oncology Drugs Revenue by Type, 2015-2020 (Million USD)
Table Asia Oncology Drugs Production Volume by Type, 2015-2020 (Volume)
Table Asia Oncology Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Table Asia Oncology Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Table Asia Oncology Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Asia Oncology Drugs Consumption Volume by Region, 2015-2020 (Volume)
Table Oceania Oncology Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Oceania Oncology Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Oceania Oncology Drugs Revenue by Type, 2015-2020 (Million USD)
Table Oceania Oncology Drugs Production Volume by Type, 2015-2020 (Volume)
Table Oceania Oncology Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Table Oceania Oncology Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Table Oceania Oncology Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Oceania Oncology Drugs Consumption Volume by Region, 2015-2020 (Volume)
Table Africa Oncology Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Africa Oncology Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Africa Oncology Drugs Revenue by Type, 2015-2020 (Million USD)
Table Africa Oncology Drugs Production Volume by Type, 2015-2020 (Volume)
Table Africa Oncology Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Table Africa Oncology Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Table Africa Oncology Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Africa Oncology Drugs Consumption Volume by Region, 2015-2020 (Volume)
Table Global Oncology Drugs Revenue by Type, 2020E-2025F (Million USD)
Table Global Oncology Drugs Production Volume by Type, 2020E-2025F (Volume)
Table Global Oncology Drugs Consumption Value by End-Use, 2020E-2025F (Million USD)
Table Global Oncology Drugs Consumption Volume by End-Use, 2020E-2025F (Volume)
Table Global Oncology Drugs Consumption Value by Region, 2020E-2025F (Million USD)
Table Global Oncology Drugs Consumption Volume by Region, 2020E-2025F (Volume)
Table Novartis A.G Overview List
Table Business Operation of Novartis A.G (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Laboratrio Cristlia Overview List
Table Business Operation of Laboratrio Cristlia (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Medley Genomics Overview List
Table Business Operation of Medley Genomics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table F. Hoffmann-La Roche Ltd Overview List
Table Business Operation of F. Hoffmann-La Roche Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Icon Plc. Overview List
Table Business Operation of Icon Plc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanofi S.A. Overview List
Table Business Operation of Sanofi S.A. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Laboratoires Pierre Fabre Overview List
Table Business Operation of Laboratoires Pierre Fabre (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Eurofarma Laboratrios S.A. Overview List
Table Business Operation of Eurofarma Laboratrios S.A. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Ach Laboratrios Farmacuticos S.A. Overview List
Table Business Operation of Ach Laboratrios Farmacuticos S.A. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Laboratorios IMA Overview List
Table Business Operation of Laboratorios IMA (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Oncology Drugs Sales Revenue 2015-2020E, by Companies, in USD Million
Table Global Oncology Drugs Sales Revenue Share, 2015-2020E, by Companies, in USD
Table Global Oncology Drugs Sales Volume by Companies, 2015-2020E (Volume)
Table Global Oncology Drugs Sales Volume Share by Companies, 2015-2020E (Volume)

List of Figures

Figure Europe Oncology Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Europe Oncology Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure America Oncology Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure America Oncology Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Asia Oncology Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure AsiaOncology Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Oceania Oncology Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Oceania Oncology Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Africa Oncology Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Africa Oncology Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Global Oncology Drugs Revenue Share by Type in 2020 (Million USD)
Figure Global Oncology Drugs Production Volume Share by Type in 2020 (Volume)
Figure Global Oncology Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Figure Global Oncology Drugs Consumption Volume Share by End-Use in 2020 (Volume)
Figure Europe Oncology Drugs Revenue Share by Type in 2020 (Million USD)
Figure Europe Oncology Drugs Production Volume Share by Type in 2020 (Volume)
Figure Europe Oncology Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Figure Europe Oncology Drugs Consumption Volume Share by End-Use in 2020 (Volume)
Figure America Oncology Drugs Revenue Share by Type in 2020 (Million USD)
Figure America Oncology Drugs Production Volume Share by Type in 2020 (Volume)
Figure America Oncology Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Figure America Oncology Drugs Consumption Volume Share by End-Use in 2020 (Volume)
Figure Asia Oncology Drugs Revenue Share by Type in 2020 (Million USD)
Figure Asia Oncology Drugs Production Volume Share by Type in 2020 (Volume)
Figure Asia Oncology Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Figure Asia Oncology Drugs Consumption Volume Share by End-Use in 2020 (Volume)
Figure Oceania Oncology Drugs Revenue Share by Type in 2020 (Million USD)
Figure Oceania Oncology Drugs Production Volume Share by Type in 2020 (Volume)
Figure Oceania Oncology Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Figure Oceania Oncology Drugs Consumption Volume Share by End-Use in 2020 (Volume)
Figure Africa Oncology Drugs Revenue Share by Type in 2020 (Million USD)
Figure Africa Oncology Drugs Production Volume Share by Type in 2020 (Volume)
Figure Africa Oncology Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Figure Africa Oncology Drugs Consumption Volume Share by End-Use in 2020 (Volume)
Figure Global Oncology Drugs Revenue and Growth Rate Forecast 2020E-2025F (Million USD)
Figure Global Oncology Drugs Production Volume and Growth Rate Forecast 2020E-2025F (Volume)
Figure Global Oncology Drugs Revenue Share by Type in 2025 (Million USD)
Figure Global Oncology Drugs Production Volume Share by Type in 2025 (Volume)
Figure Global Oncology Drugs Consumption Value Share by End-Use in 2025 (Million USD)
Figure Global Oncology Drugs Consumption Value Share by Region in 2025 (Million USD)
Figure Global Oncology Drugs Consumption Volume Share by Region in 2025 (Volume)
  • Global 5-Fluorouracil Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 76
    The global 5-Fluorouracil market was valued at US$ 283 million in 2023 and is anticipated to reach US$ 487.9 million by 2030, witnessing a CAGR of 4.3% during The forecast period 2024-2030. North American market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by ......
  • Global Carboplatin Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global Carboplatin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % d......
  • Global Neutropenia Drugs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 96
    The global Neutropenia Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated to increa......
  • Global Small Molecule Cancer Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Small Molecule Cancer Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated ......
  • Global Capecitabine Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 80
    Capecitabine is an orally-administered chemotherapeutic agent used in The treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in The tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Common side effects include abdominal pain, vomiting, diarrhea, weakness, and rashes. Other severe side effects include blood clotting problems, allergic reactions, heart problems, and low blo......
  • Global Oxaliplatin Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104
    Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy The third stage colon cancer after resecting primary tumor completely. In this report, only The finished drug is covered, exclude API. The global Oxaliplatin market was valued at US$ 897.5 million in 2023 and is anticipated to reach US$ 1641.5 million by 2030, witnessing a CAGR of 8.9% duri......
  • Global Cancer Treatment Drugs Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158
    According to our LPI (LP Information) latest study, the global Cancer Treatment Drugs market size was valued at US$ 174990 million in 2023. With growing demand in downstream market, the Cancer Treatment Drugs is forecast to a readjusted size of US$ 322540 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Cancer Treatment Drugs market. Cancer Treatment Drugs are expected to show stable growth in the future market. H......
  • Global Capecitabine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 93
    According to our LPI (LP Information) latest study, the global Capecitabine market size was valued at US$ 1003.9 million in 2023. With growing demand in downstream market, the Capecitabine is forecast to a readjusted size of US$ 975.1 million by 2030 with a CAGR of -0.4% during review period. The research report highlights the growth potential of the global Capecitabine market. Capecitabine are expected to show stable growth in the future market. However, product differentiation, reducin......
  • Global Methotrexate Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95
    According to our LPI (LP Information) latest study, the global Methotrexate market size was valued at US$ 506 million in 2023. With growing demand in downstream market, the Methotrexate is forecast to a readjusted size of US$ 613.9 million by 2030 with a CAGR of 2.8% during review period. The research report highlights the growth potential of the global Methotrexate market. Methotrexate are expected to show stable growth in the future market. However, product differentiation, reducing co......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs